14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $65.50 $76.39 Thursday, 2nd May 2024 AXSM stock ended at $74.19. This is 0.93% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 2.03% from a day low at $73.52 to a day high of $75.01.
90 days $65.50 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
May 10, 2021 $55.36 $56.78 $53.78 $54.39 349 399
May 07, 2021 $56.44 $57.99 $56.00 $56.96 308 024
May 06, 2021 $58.45 $58.45 $55.00 $56.36 477 702
May 05, 2021 $58.77 $59.65 $57.47 $58.15 340 249
May 04, 2021 $60.86 $60.98 $57.78 $58.08 571 560
May 03, 2021 $61.54 $62.41 $60.71 $61.55 319 431
Apr 30, 2021 $61.18 $63.00 $59.52 $60.46 411 137
Apr 29, 2021 $59.81 $62.46 $58.63 $61.78 321 435
Apr 28, 2021 $60.84 $62.25 $59.00 $59.74 581 892
Apr 27, 2021 $59.81 $64.97 $59.51 $60.39 1 167 770
Apr 26, 2021 $58.63 $61.50 $56.41 $58.71 1 353 886
Apr 23, 2021 $52.86 $54.14 $51.20 $52.89 371 245
Apr 22, 2021 $54.92 $55.50 $52.87 $52.87 506 530
Apr 21, 2021 $50.68 $54.62 $50.05 $54.60 526 514
Apr 20, 2021 $51.75 $53.07 $50.18 $50.63 484 788
Apr 19, 2021 $53.48 $54.37 $51.13 $51.93 202 848
Apr 16, 2021 $52.60 $53.56 $51.68 $53.44 250 384
Apr 15, 2021 $53.69 $54.75 $52.11 $52.60 198 060
Apr 14, 2021 $51.50 $55.20 $51.23 $53.55 272 758
Apr 13, 2021 $51.90 $52.39 $51.00 $51.71 384 156
Apr 12, 2021 $52.70 $53.18 $51.51 $51.89 325 071
Apr 09, 2021 $53.61 $54.57 $52.84 $52.99 271 017
Apr 08, 2021 $55.22 $55.43 $53.63 $54.09 211 546
Apr 07, 2021 $55.98 $56.55 $54.14 $54.24 170 560
Apr 06, 2021 $57.20 $57.75 $56.00 $56.23 165 069
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT